Huaxia Eye Hospital Group Co.,Ltd. (SHE:301267)
China · Delayed Price · Currency is CNY 14.71
-0.03 (-0.20%)
At close: Sep 16, 2026
Huaxia Eye Hospital Group Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 12,271 | 14,968 | 15,868 | 26,956 | 40,942 | - | |
Market Cap Growth | -31.92% | -5.67% | -41.13% | -34.16% | - | - |
Enterprise Value | 9,514 | 12,317 | 13,292 | 23,696 | 40,265 | - |
Last Close Price | 14.74 | 17.78 | 18.52 | 31.05 | 46.93 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 27.27 | 33.97 | 37.02 | 40.48 | 79.68 | - |
Forward PE | 23.40 | 29.97 | 20.33 | 34.32 | - | - |
PS Ratio | 2.93 | 3.62 | 3.94 | 6.72 | 12.66 | - |
PB Ratio | 2.19 | 2.75 | 2.63 | 4.72 | 7.98 | - |
P/TBV Ratio | 2.60 | 3.27 | 3.09 | 5.01 | 8.28 | - |
P/FCF Ratio | 16.86 | 23.55 | 29.35 | 52.56 | 76.57 | - |
P/OCF Ratio | 13.27 | 17.25 | 19.35 | 28.04 | 53.17 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 2.27 | 2.98 | 3.30 | 5.91 | 12.45 | - |
EV/EBITDA Ratio | 10.41 | 15.76 | 17.39 | 23.06 | 45.81 | - |
EV/EBIT Ratio | 15.81 | 20.02 | 22.36 | 26.96 | 55.59 | - |
EV/FCF Ratio | 13.07 | 19.38 | 24.58 | 46.21 | 75.31 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.19 | 0.21 | 0.16 | 0.13 | 0.14 | 0.36 |
Debt / EBITDA Ratio | 1.16 | 1.22 | 1.08 | 0.64 | 0.72 | 0.72 |
Debt / FCF Ratio | 1.46 | 1.79 | 1.80 | 1.44 | 1.35 | 1.05 |
Net Debt / Equity Ratio | -0.52 | -0.47 | -0.53 | -0.61 | -0.67 | -0.16 |
Net Debt / EBITDA Ratio | -3.83 | -3.31 | -4.16 | -3.41 | -3.89 | -0.37 |
Net Debt / FCF Ratio | -4.03 | -4.07 | -5.88 | -6.83 | -6.40 | -0.47 |
Asset Turnover | 0.53 | 0.54 | 0.53 | 0.57 | 0.65 | 1.14 |
Inventory Turnover | 11.60 | 14.03 | 12.28 | 11.28 | 11.92 | 14.29 |
Quick Ratio | 3.32 | 3.62 | 4.38 | 4.59 | 5.55 | 1.49 |
Current Ratio | 3.54 | 3.84 | 4.65 | 4.88 | 5.85 | 1.71 |
Return on Equity (ROE) | 7.48% | 7.55% | 7.29% | 12.49% | 14.59% | 27.49% |
Return on Assets (ROA) | 4.72% | 4.97% | 4.86% | 7.78% | 9.09% | 15.07% |
Return on Invested Capital (ROIC) | 16.58% | 16.28% | 17.88% | 35.54% | 34.61% | 40.46% |
Return on Capital Employed (ROCE) | 9.30% | 9.60% | 8.60% | 13.80% | 12.20% | 26.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 3.67% | 2.94% | 2.70% | 2.47% | 1.26% | - |
FCF Yield | 5.93% | 4.25% | 3.41% | 1.90% | 1.31% | - |
Dividend Yield | 1.74% | 1.46% | 1.19% | 0.35% | 0.40% | - |
Payout Ratio | 48.11% | 58.56% | 21.39% | 23.55% | - | 0.03% |
Buyback Yield / Dilution | 0.77% | 1.08% | 0.29% | -9.92% | -2.28% | -0.14% |
Total Shareholder Return | 2.50% | 2.54% | 1.48% | -9.56% | -1.88% | -0.14% |